Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA and protein oxidation refers to the oxidative modification of cellular DNA and proteins, primarily by reactive oxygen species (ROS), peroxides, and free radicals. DNA oxidation results in lesions such as 8-oxo-2'-deoxyguanosine, altering base pairing, gene expression, and increasing mutagenesis risk. Protein oxidation affects amino acids like cysteine and methionine, leading to reversible or irreversible modifications, protein unfolding, degradation, or altered function. These processes play major roles in genetic regulation, cell signaling, adaptation responses, cellular aging, and are implicated in many pathologies including cancer, neurodegeneration, infection, and cardiovascular disease. Oxidative damage of DNA and proteins is also a therapeutic strategy to kill pathogens or cancer cells, but is not a discrete molecular target like a receptor or enzyme.
Scavenging of reactive oxygen species (ROS); Enhancement or inhibition of DNA repair enzymes (e.g., OGG1 involved in repair of 8-oxoguanine lesions); Inducing oxidative stress
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA and protein oxidation.